Typically, stage 4 prostate cancer patients do not achieve remission with standard chemotherapy regimens and testosterone blocking agents, such as Lupron. Moreover, a major side effect of Lupron and other similar agents, which are used to slow down the development of stage 4 prostate cancer, is breast growth and tenderness. This and other estrogen-dominant related side effects can harmfully impact men's overall long-term health, energy and vitality.
These common regimens are typically followed by radiation to treat the metastatic bone sites, in an effort to improve quality of life for stage 4 prostate cancers. In fact, tumor boards and hospital cancer discussion panels are typically limited to palliative radiotherapy for stage 4 prostate cancer patients.
In short, stage 4 prostate cancer has been in desperate need of new innovative approaches like gene-targeted chemotherapy for quite some time. There have been definite improvements in early prostate cancer treatments, including less invasive techniques like robotic surgery and Cyber Knife. Let us share with you a better approach to stage 4 prostate cancer. We will also discuss key immunotherapy cancer treatment options that are essential for stage 4 prostate cancer.
This technology may someday replace much of radiation and surgical treatments. It allows for real-time tumor destruction (within one to two days) and treatment of bones metastasis without harming the immune system. It will allow direct targeting of chemotherapy agents over tumors like photodynamic but with more precision and targeting.
Stage 4 Cancer Solutions in Effect
Envita's stage 4 prostate treatments and solutions are innovative and incorporate world-class technology. Not long ago, an FDA-approved vaccine called Provenge was presented, using 15 year old dendritic cell technology, similar to that touted by the Germans and used in Asian countries to battle cancer. This is what we call "dendritic cell immunotherapy" and it plays a critical role with regard to stage 4 prostate cancer patients.
However, we think the technology is outdated. Why? In 2006, Envita's research team developed what we call "the world's first intelligent cancer treatment," which actually processes the latest advancements in Natural Killer (NK) Cell Immunotherapy to assist cancer patients. Envita's proprietary and innovative solutions may help cancer patients attain significant results.
Natural Killer Cells are the key. Even dendritic cell vaccines work by passing information over to the NK cells, AAIT actually provides a final product that kills the tumor in stage 4 prostate cancer patients. Billions of targeted NK cells are ready to destroy tumors and more importantly stop metastasis. Here is data to review on AAIT and cancer.
Common Bone Metastasis Solutions For Stage 4 Cancer
We believe that new dynamic innovations using high-intensity, focused ultrasound, will soon replace some radiotherapy used to treat bone cancers, especially metastatic bone stage 4 prostate cancer. Bone metastasis is commonly found in prostate and breast cancer, as well as other late stage cancers. This stellar technology, MR-HIFU, allows for the destruction of cancer with only one or two treatments and without the use of radiation.
This is critical, as it can spare patients' additional physical stress and the weakening of their immune systems. Via MRI treatment, it is possible to see the tumor destruction instantly. Philips HIFU is a great place for you to learn more about Envita's technology being made available to stage 4 prostate cancer patients. This, in many cases, eliminates most radiation treatments in the future.
Here is another version of HIFU used in earlier stage 4 prostate cancer
Making a Lasting Impact
Naturally, more treatment options are customized and incorporated for Envita's Stage 4 prostate cancer patients, but they are administered based on independent factors and genetic, immunological information gathered through testing. Even when we utilize chemotherapy, it is done in a customized and low-dose targeted manner, completely unique to Envita.
Vital, Independent Factors for Stage 4 Prostate Cancer
It is necessary to maintain focus on the primary causes that nourish cancer – these are epigenetic, environmental and genetic factors. Other factors may include infection, toxicity, hormone imbalances, genetic hormonal shifts, plus chronic inflammations that feed the growth of stage 4 prostate cancer and most other cancers.
Essentially, Envita employs targeted and aggressive methods to alter the body's environment so that it remains inhospitable to cancer and its growth. Diet and lifestyle changes, though important, are just not potent enough on their own. If used alone with stage 4 prostate cancer patients, we cannot honestly expect desirable outcomes. Envita's proprietary treatments allow the host to maintain an environment that is not conducive to cancer growth and spread, while strengthening our patients' quality of life throughout the process.
To discover more about which solutions can aid you and your particular cancer, contact us today. Let us help you build a powerful and personalized plan for success.
Is your chemotherapy or cancer treatment plan working in the way you hoped for? This is a question that patients and their loved ones have asked each other during the course of tre...
Over 15 years of specialization in late-stage and complex cancers has finally revealed the best strategies for doctors to bring forth better results with patients. This article aim...
Why didn't my chemotherapy work? This is a question that many cancer patients know all too well, but why are patients becoming unresponsive to chemotherapy? What can be done to dra...
Immunotherapy is the new hot-topic in cancer treatment discussions, but what exactly is it? Immunotherapy is a cancer treatment designed to boost the body's natural ability to figh...
Imagine yourself on chemotherapy and your drugs at first seem to be helping you win your fight against cancer – but you're also incredibly weak, your immunity is shot and now, your...